Dr. Daniel Scherman is the Director of the Foundation for Rare Diseases (FFRD), Head of the Medicine and Life Sciences Division of the European Academy of Sciences EURASC, and Exceptional Class Director of CNRS National Scientific Research Center France. He holds a Ph.D. degree from Université Paris. His expertises are focused on rare diseases, drug delivery and targeting, gene therapy, non-viral gene delivery, in vivo imaging, molecular pharmacology, neurology, and cell biology. He was elected a Member of the European Academy of Science EURASC (2016) and elected Member of the Académie Nationale de Pharmacie (2020).
Dr. Daniel Scherman is the Director of the Foundation for Rare Diseases (FFRD), Head of the Medicine and Life Sciences Division of the European Academy of Sciences EURASC, and Exceptional Class Director of CNRS National Scientific Research Center France. He holds a Ph.D. degree from Université Paris. His expertises are focused on rare diseases, drug delivery and targeting, gene therapy, non-viral gene delivery, in vivo imaging, molecular pharmacology, neurology, and cell biology. He was elected a Member of the European Academy of Science EURASC (2016) and elected Member of the Académie Nationale de Pharmacie (2020).